awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36848631-5EAD906D-E374-4826-BAA4-ADEDAD020FBD
Q36848631-5EAD906D-E374-4826-BAA4-ADEDAD020FBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36848631-5EAD906D-E374-4826-BAA4-ADEDAD020FBD
Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.
P2860
Q36848631-5EAD906D-E374-4826-BAA4-ADEDAD020FBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36848631-5EAD906D-E374-4826-BAA4-ADEDAD020FBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a9e7ff36f0b7cd52217e2bafd9e79f6a48a845d
P2860
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATA